E-Therapeutics competitorsClear all

E-Therapeutics's top competitors include Opiant Pharmaceuticals, Vitality Biopharma, IntelGenx and Adamas Pharmaceuticals.
E-Therapeutics
E-Therapeutics
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
Vitality Biopharma
Vitality Biopharma
Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.
IntelGenx
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
Adamas Pharmaceuticals
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Founding Date
Founding Date
2003
Founding Date
2009
Founding Date
2012
Founding Date
2003
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Long Hanborough, GB HQ
Newcastle Upon Tyne, GB
Locations
Santa Monica, US HQ
London, GB
Locations
Los Angeles, US HQ
Locations
Saint-Laurent, CA HQ
Locations
Emeryville, US HQ
Employees
Employees
2017% decrease
Employees
1614% increase
Employees
814% increase
Employees
3819% increase
Employees
1345% decrease
Valuation ($)
Valuation ($)
36.1 m
Valuation ($)
51.2 m
Valuation ($)
38.8 m
Valuation ($)
50.1 m
Valuation ($)
126.9 m
Alexa Website Rank
Alexa Website Rank
454059
Alexa Website Rank
248131
Alexa Website Rank
250428
Alexa Website Rank
341162
Alexa Website Rank
161610

Financial

Revenue (est.)
Revenue (est.)
£44k (FY, 2019)
Revenue (est.)
$14m (FY, 2018)
Revenue (est.)
$258.3k (FY, 2019)
Revenue (est.)
$1.8m (FY, 2018)
Revenue (est.)
$34m (FY, 2018)
Net income
Net income
(£4m) (FY, 2019)
Net income
($21.2m) (FY, 2018)
Net income
($13.1m) (FY, 2019)
Net income
($10.1m) (FY, 2018)
Net income
($131m) (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
$ 82m
For sources of this data, please see the company profile

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
16↑ 14% increase

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
Vitality Biopharma
HQ
Los Angeles, US
Employees
8↑ 14% increase

Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
38↑ 19% increase

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
134↓ 5% decrease

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company